Rola Hammoud

Rola Hammoud is a postdoctoral scientist in Dr. Daniel Drucker’s lab at Mount Sinai Hospital, where she is researching the gut hormone GIP in relation to tirzepatide, a dual-action drug for diabetes and weight loss. With a background in nutritional science, she emphasizes the complex physiological processes influencing weight loss and appetite control, challenging the notion that these issues are solely a matter of willpower.